SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies
May 12, 2025
 · 
4 min read
Press Releases
Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025
May 12, 2025
 · 
2 min read
Press Releases
Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States
May 12, 2025
 · 
6 min read
Press Releases
Almirall Q1 2025 Results
May 12, 2025
 · 
8 min read
Press Releases
Allarity Therapeutics Provides First Quarter 2025 Update, Highlighting Continued Stenoparib Benefit and Upcoming Trial Enrollment
May 12, 2025
 · 
11 min read
Press Releases
Oculis Publishes Invitation to the Annual General Meeting
May 12, 2025
 · 
1 min read
Press Releases
Entera Bio Announces First Quarter 2025 Financial Results and Business Updates
May 12, 2025
 · 
15 min read
Press Releases
Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates
May 12, 2025
 · 
9 min read
Press Releases
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 9, 2025
May 12, 2025
 · 
1 min read
Press Releases
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 9, 2025
May 12, 2025
 · 
2 min read
Press Releases
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 9, 2025
May 12, 2025
 · 
5 min read
Press Releases
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 9, 2025
May 12, 2025
 · 
2 min read
Press Releases
AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
May 12, 2025
 · 
2 min read
Press Releases
Coave Therapeutics Launches coAAV-CSF-01, a Novel CNS-Targeted Gene Therapy Vector for Neurodegenerative and other CNS Diseases
May 12, 2025
 · 
4 min read
Press Releases
Olema Oncology to Participate in Upcoming May 2025 Investor Conferences
May 12, 2025
 · 
1 min read
Press Releases
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 9, 2025
May 12, 2025
 · 
1 min read
Press Releases
Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting
May 12, 2025
 · 
6 min read
Press Releases
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
May 12, 2025
 · 
6 min read
Press Releases
Stevanato Group to Participate in Upcoming Investor Conferences - May 9, 2025
May 12, 2025
 · 
1 min read
Press Releases
Rocket Pharmaceuticals Announces Late-Breaking Oral Presentation of Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy Accepted at 28th Annual Meeting of the American Society of Gene and Cell Therapy
May 12, 2025
 · 
7 min read
Press Releases
Arcus Biosciences Announces New Employment Inducement Grants - May 9, 2025
May 12, 2025
 · 
1 min read
Press Releases
Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 9, 2025
May 12, 2025
 · 
2 min read
Press Releases
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 9, 2025
May 12, 2025
 · 
2 min read
Press Releases
AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting
May 12, 2025
 · 
4 min read
Press Releases
ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance
May 12, 2025
 · 
27 min read
Press Releases
Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Trial in the New England Journal of Medicine
May 12, 2025
 · 
7 min read
Press Releases
Anika Reports First Quarter 2025 Financial Results
May 12, 2025
 · 
15 min read
Press Releases
uniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress
May 12, 2025
 · 
14 min read
Press Releases
Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
May 12, 2025
 · 
8 min read
Press Releases
Kymera Therapeutics Expands Industry Leading Immunology Pipeline with New First-in-Class, Oral IRF5 Degrader Program with Potential to Address Multiple Immuno-Inflammatory Diseases
May 12, 2025
 · 
8 min read
Press Releases
InspireMD Reports First Quarter 2025 Financial Results
May 12, 2025
 · 
10 min read
Press Releases
Real-World Study Confirms Long-Term Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with the DecisionDx-UM Class Result
May 12, 2025
 · 
6 min read
Press Releases
Protagonist Announces Icotrokinra Phase 3 Data on Difficult-to-Treat Scalp and Genital Psoriasis and Preclinical Data on PN-881 Presented at the Society for Investigative Dermatology Annual Meeting
May 12, 2025
 · 
12 min read
Press Releases
Icotrokinra results show significant skin clearance in patients with difficult-to-treat scalp and genital psoriasis
May 12, 2025
 · 
15 min read
Load More